CSF2 and cancer: Elevated GM‐CSF in plasma was found in patients with CRC; unlike in other malignant tumors, ectopic secretion of GM‐CSF driven by demethylation of its gene promoter has demonstrated an immune‐independent mediated antitumor effect [146].